Market research
600557.SHG Jiangsu Kanion Pharmaceutical Co.,Ltd
SHG CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 7B
- P/E ratio
- 21.6
- Analyst target
- 15.655
- Dividend yield
- Not available
- Beta
- 0.42
Community
Investor discussion
1 comment
Sign in to join the 600557.SHG discussion.
5 years, 5 months ago
Jiangsu Kanion Pharmaceutical Co.,Ltd is currently in a long term uptrend where the price is trading 5.8% above its 200 day moving average.
From a valuation standpoint, the stock is 82.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.7.
Jiangsu Kanion Pharmaceutical Co.,Ltd's total revenue sank by 34.4% to $724M since the same quarter in the previous year.
Its net income has dropped by 66.8% to $43M since the same quarter in the previous year.
Finally, its free cash flow fell by 68.1% to $50M since the same quarter in the previous year.
Based on the above factors, Jiangsu Kanion Pharmaceutical Co.,Ltd gets an overall score of 2/5.